Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4575966
Max Phase: Preclinical
Molecular Formula: C22H21N3O5
Molecular Weight: 407.43
Molecule Type: Unknown
Associated Items:
ID: ALA4575966
Max Phase: Preclinical
Molecular Formula: C22H21N3O5
Molecular Weight: 407.43
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cc(C(=O)c2c[nH]c(-c3c[nH]c4c(OC)cccc34)n2)cc(OC)c1OC
Standard InChI: InChI=1S/C22H21N3O5/c1-27-16-7-5-6-13-14(10-23-19(13)16)22-24-11-15(25-22)20(26)12-8-17(28-2)21(30-4)18(9-12)29-3/h5-11,23H,1-4H3,(H,24,25)
Standard InChI Key: HHRJRYWNKNHCBE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 407.43 | Molecular Weight (Monoisotopic): 407.1481 | AlogP: 3.82 | #Rotatable Bonds: 7 |
Polar Surface Area: 98.46 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.96 | CX Basic pKa: 3.95 | CX LogP: 3.19 | CX LogD: 3.19 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.45 | Np Likeness Score: -0.05 |
1. Wang Q, Arnst KE, Wang Y, Kumar G, Ma D, White SW, Miller DD, Li W, Li W.. (2019) Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin., 62 (14): [PMID:31251599] [10.1021/acs.jmedchem.9b00706] |
Source(1):